Revived Alzheimer's Symptomatic Drug Set to Test as Donepezil Combo

BARCELONA — RVT-101, a novel small molecule that increases acetylcholine release, is poised for what its developers say could be its pivotal trial for U.S. approval.
Source: Caring for the Ages - Category: Health Management Authors: Source Type: news